An interview with Shane Needham (Alturas Analytics) on the development and validation of assays

In this Bioanalysis Zone interview, Shane Needham (Alturas Analytics; ID, USA) discusses the advantages and disadvantages of the technologies employed by Alturas Analytics, including microflow LC–MS. Shane further explains how to overcome the challenges associated with developing and validating assays, before predicting what the field may look like in 5–10 years’ time.

Interested in LC–MS? You might also like…

Shane-circleAn interview with Shane Needham on data sharing, ALICE technology and co-founding a CRO




BioJournals-zoom-left-12802017 White Paper on recent issues in bioanalysis: rise of hybrid LBA/LCMS immunogenicity assays




yellow antibodiesPanel discussion on large molecule quantification by LC–MS